Based on our local coverage from Spain, the Netherlands and France and in an environment of decelerating inflation, we set the following hierarchy: Jeronimo Martins as our Top Pick for its growth potential, while in the slow-growth retail category, we favour Ahold Delhaize over Carrefour (downgraded to Neutral) or Colruyt. - >Managing inflation & food inflation deceleration: the name of the game for 2024 - The key topic for food retailers in 2024 will be how they manag...
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we comment on the US-Europe decoupling as US GDP growth forecasts for 2024 become in
>Q4 2024 outlook: company sees some signs of food inflation abatement - As usual, management’s outlook for 2024 was unspecific in terms of sales growth or margins, they just stated that cost inflation (rent and salaries) and Food CPI deflation will pressure the margins and that management will keep the focus on growing volumes. The company stated that the group will face tough comps in FY 2024 yet they believe that the strength and differentiation of their value prop...
With food deflation now the base scenario for Jeronimo Martins in H1 while a price war is reviving in Poland, we expect sluggish momentum during H1 with low to no top-line growth and EBITDA/FCF under significant pressure. PT cut from EUR21 to EUR20. Pending a potential improvement in momentum as of
We are initiating coverage of Lonza with a target price of CHF 535 and an Outperform rating. As one of the world's leading contract development and manufacturing organisations (CDMO), Lonza is predestined to benefit from the sustainable drivers of this industry. The group's global presence and strong market positions in the growth areas of biologics and cell and gene therapy (CGT) will fuel double-digit sales growth and >30% EBITDA margins in the medium term. Despite significant growt...
We are initiating coverage of Lonza with a target price of CHF 535 and an Outperform rating. As one of the world's leading contract development and manufacturing organisations (CDMO), Lonza is predestined to benefit from the sustainable drivers of this industry. The group's global presence and strong market positions in the growth areas of biologics and cell and gene therapy (CGT) will fuel double-digit sales growth and >30% EBITDA margins in the medium term. Despite significant growt...
>Solid inflation-fuelled sales - The company released its Q4 sales earlier this year. Sales grew at a pace of +17% y-o-y to € 8.1bn (vs +22% in Q3) with the group’s l-f-l expanding at +10% (vs +12% in Q3). By business, Biedronka sales grew +17% to € 5.7bn, decelerating vs Q3 (+24%) as the lower LFL (+5.1% Q4 vs +13% in Q3) is partially offset by FX (+8pp) and space growth (4pp). The price impact is already negative for certain categories in Q4. Hebe: sales grew +32% t...
Jeronimo Martins has officially admitted 2024 will be a tough year marked by food deflation and a revived price war in Poland, issuing disappointing guidance for stronger margin pressure and lower FCF generation. This confirms the fears that led us to downgrade the stock in mid-January, and we now
HEADLINES: • PKO BP: posts solid 4Q23/2023 results NEUTRAL • Poland macro: NBP on hold, with a cautious bias • CTP: 4Q23 – yet another quarter with a strong, positive revaluation gain POSITIVE • Jeronimo Martins: 4Q23 in line with expectations; FY24E guidance for possibly deeper margins erosion NEGATIVE • Electrica: rather disappointing 2024E budget NEGATIVE • Electrica: proposes RON 0.1178 DPS and looking to issue green bonds NEUTRAL • PGE: weaker qoq EBITDA in 4Q23, but expected NEUTRAL • Data...
EME Equity Market – February 2024 Market performance – a positive February, with the Polish WIG20 outperforming. The MSCI EM Europe Index added 4.2% mom in EUR terms and 3.7% mom in USD in February. The Polish WIG20 saw the strongest performance, adding 6.4% mom in EUR terms, followed by the Greek ASE (+4.2% mom), the Turkish ISE30 (+4.0% mom) and the Romanian BET (+2.6% mom) (all in EUR terms). There was a relatively muted performance in Hungary (+0.6% mom in EUR terms) and a decline in the Cze...
The start of the earnings season has halted EPS erosion, which was marked in Europe and more limited in the US. In 2024, EPS should grow twice as fast on the S&P 500 (+10%) vs the Stoxx 600 (+5%). In Europe, the fastest-growing sectors are travel & leisure, banks and industrials. - ...
L’ouverture de la saison des résultats a mis fin à l’érosion des BPA, qui était forte en Europe et plus limitée aux Etats-Unis. Les BPA devraient ainsi croître en 2024 deux fois plus vite sur le S&P 500 (+10%) que le sur le Stoxx 600 (+5%). En Europe, les secteurs ayant la meilleure dynamique sont le Travel & Leisure, les Banques et l’Industrie. - ...
>Q4 2023 earnings preview - JMT is due to publish its Q4 results on 6 March. The company already released it sales figure, which grew +17% y-o-y to € 8.1bn (vs +22% in Q3). We expect margin deterioration of 24bp to 7.0% (vs -24bp in Q3) as the competitive environment in all regions remains challenging while volume growth, although positive, is not sufficient to fully offset the softening food inflation. Despite this margin deterioration we expect the bottom-line to ou...
HEADLINES: • Bank of Georgia: thoughts on the Ameria acquisition POSITIVE • Eurocash: antimonopoly court waives PLN 76m fine POSITIVE • Budimex: PLN 2.3m best offers for S10 express road sections POSITIVE • Warsaw Stock Exchange: 4Q23E preview (due out tomorrow) • Orlen: 4Q23E results preview (due on 22 February) NEUTRAL • Jeronimo Martins: 4Q23E results preview – 9% yoy EBITDA growth expected (due on 6 March) • Dino: 4Q23E results preview – 16% yoy EBITDA growth expected (due on 21 March) • LPP...
HEADLINES: • KazMunayGas: energy without the obstructions (BUY - transfer of coverage) • MOL: 4Q23 results – net income well above expectations POSITIVE • Solutions by STC: 4Q23 financial results review – miss on profitability estimates, but in line with 2023 guidance NEUTRAL • Orange Polska: key takeaways from the 4Q23 earnings call NEUTRAL • Hidroelectrica: price caps to remain in place until 31 March 2025 NEUTRAL • Jeronimo Martins: another step from Biedronka on the way to ecommerce • El...
EME Equity Market – January 2024 Market performance – Turkey off to the races in January. The MSCI EM Europe Index added 4.2% mom in EUR terms and 2.2% mom in USD in the first month of the year. There was a V-shape recovery in the Turkish ISE30, with the index adding 12.6% mom in EUR terms. The Greek ASE and Hungarian BUX indices also reported strong performances, adding 5.7% and 5.3% mom, respectively, in EUR terms. The Czech PX Index advanced by 2.2% mom, while the Romanian BET 0.9% mom in EUR...
We host our 27th ODDO BHF Forum in Lyon in 11th and 12th January 2024 and virtually 15th and 16th January 2024. In total, 335 companies will be presenting. In the following note, we provide some initial feedback of the company on day 1. - ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.